Last reviewed · How we verify
NCT06206590
Analysis of Differential Proteins and Maternal Influencing Factors of Septic Shock in Neonates
trial testing Whole-proteomic assay in Neonatal Disease in 116 participants. Status unknown.
1 September 2025
Quick facts
| Lead sponsor | Guangdong Women and Children Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 116 |
| Start date | 1 November 2023 |
| Primary completion | 1 September 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Whole-proteomic assay
Conditions studied
- Neonatal Disease — all drugs for Neonatal Disease →
Sponsor
Guangdong Women and Children Hospital
Who can join
Adults 1 Day to 1 Day, any sex, with Neonatal Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1\. Explore 32 weeks of premature infants or maternal pregnancy infection of newborn septic shock maternal influence factors. 2. Through maternal blood samples before delivery and labor cord blood sample screening and septic shock related proteomics analysis, explore the relationship between the difference protein and septic shock and prognosis, and explore the pathway mechanism, in order to prevent and reduce the occurrence of septic shock in premature infants
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06206590
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neonatal Disease
Currently open trials in the same condition.
- NCT06545565 — Prevention of Metabolic Acidosis in Preterm Neonates by Replacing Sodium Chloride With Sodium Acetate in Parenteral Nutr · Phase 3 · recruiting
- NCT06458699 — Management Of Stoma In Patients Younger Than 3 Months Old · active not recruiting
- NCT06408480 — Neonatologist-performed Lung Ultrasound in the Delivery Room · recruiting
- NCT06258187 — Pedi-Cap CO2 Detector for Face-mask Ventilation in the Delivery Room · NA · active not recruiting
- NCT06594458 — New Procedure to Reduce Mother-newborn Separation · NA · recruiting
Other Guangdong Women and Children Hospital trials
Trials by the same sponsor.
- NCT07519213 — Postoperative Hormonal Therapy and Recurrence After Surgery for Ovarian Endometrioma · completed
- NCT06371313 — Endocrine, Metabolic and Inflammatory Characteristics of Offspring of Mothers With PCOS Hyperandrogenism · completed
- NCT05872425 — Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS · NA · completed
- NCT05976529 — A Multicenter, Observational Clinical Study of Dydrogesterone · unknown
- NCT05087498 — Effect of Autologous Cord Blood-mononuclear Cells Infusion on Immune Microenvironment in Infants Born Very Preterm in NI · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06206590 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangdong Women and Children Hospital
- Last refreshed: 16 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06206590.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing